Banque Cantonale Vaudoise Has $1.18 Million Holdings in Xylem Inc. $XYL

Banque Cantonale Vaudoise reduced its stake in Xylem Inc. (NYSE:XYL) by 59.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,895 shares of the industrial products company’s stock after selling 14,317 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Xylem were worth $1,182,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the company. Assenagon Asset Management S.A. grew its holdings in shares of Xylem by 6.9% during the first quarter. Assenagon Asset Management S.A. now owns 295,610 shares of the industrial products company’s stock worth $35,325,000 after buying an additional 19,114 shares in the last quarter. Keudell Morrison Wealth Management lifted its stake in Xylem by 31.3% in the 1st quarter. Keudell Morrison Wealth Management now owns 3,010 shares of the industrial products company’s stock valued at $360,000 after acquiring an additional 718 shares in the last quarter. Richards Merrill & Peterson Inc. boosted its position in Xylem by 30.1% during the 1st quarter. Richards Merrill & Peterson Inc. now owns 2,700 shares of the industrial products company’s stock worth $323,000 after acquiring an additional 625 shares during the last quarter. Legacy Wealth Partners LLC grew its stake in shares of Xylem by 138.2% during the 1st quarter. Legacy Wealth Partners LLC now owns 5,369 shares of the industrial products company’s stock worth $642,000 after acquiring an additional 3,115 shares in the last quarter. Finally, Krilogy Financial LLC grew its stake in shares of Xylem by 12.6% during the 1st quarter. Krilogy Financial LLC now owns 2,525 shares of the industrial products company’s stock worth $316,000 after acquiring an additional 282 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Insider Activity

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer owned 3,605 shares in the company, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jerome A. Peribere purchased 1,210 shares of the stock in a transaction on Monday, May 4th. The shares were acquired at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the transaction, the director owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.32% of the company’s stock.

Analyst Upgrades and Downgrades

XYL has been the topic of a number of research reports. Barclays cut their price objective on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 29th. UBS Group raised their target price on shares of Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Stifel Nicolaus lowered their price target on shares of Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. CLSA raised shares of Xylem to a “hold” rating in a research report on Thursday. Finally, Oppenheimer reduced their price objective on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research note on Wednesday, April 29th. Eight analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $153.54.

Xylem Price Performance

NYSE:XYL opened at $116.60 on Friday. Xylem Inc. has a 1-year low of $105.29 and a 1-year high of $154.27. The company has a current ratio of 1.46, a quick ratio of 1.10 and a debt-to-equity ratio of 0.13. The firm has a fifty day simple moving average of $113.05 and a 200 day simple moving average of $125.38. The stock has a market capitalization of $27.71 billion, a PE ratio of 29.00, a P/E/G ratio of 1.66 and a beta of 1.04.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $0.03. The firm had revenue of $2.12 billion for the quarter, compared to analyst estimates of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The company’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, research analysts expect that Xylem Inc. will post 5.51 EPS for the current fiscal year.

Xylem Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were issued a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s dividend payout ratio is presently 42.79%.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.